NeurogesX Gets $40 Million To Fund U.S. Launch Of Qutenza Through Royalty Deal
This article was originally published in The Pink Sheet Daily
Executive Summary
Cowen Healthcare Royalty Partners provides the $40 million in exchange for royalties and sales milestones from areas controlled by Astellas.